Completeness and correctness of registration of renal pelvic and ureteral cancer in the Swedish Cancer Registry

Scandinavian Journal of Urology and Nephrology

Volumn 42, Issue 1, 2008, Pages 12-17

  Holmäng, Sten ^a   Amsler Nordin, Susanne ^a   Carlson, Kerstin ^a   Holmberg, Erik ^a   Johansson, Sonny L ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Neoplasm; Registration; Renal pelvis; Ureter; Validity

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER REGISTRY; HUMAN; KIDNEY PELVIS CARCINOMA; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; PRIORITY JOURNAL; QUALITY CONTROL; URETER CANCER; VALIDITY;

COHORT STUDIES; FALSE POSITIVE REACTIONS; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; KIDNEY PELVIS; REGISTRIES; REPRODUCIBILITY OF RESULTS; SWEDEN; URETERAL NEOPLASMS;

EID: 38349124813     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/00365590701520024     Document Type: Article

References (14)

1. Holm LE, Löwhagen T, Silfverswärd C. The reliability of malignant thyroid tumor diagnosis in the Swedish Cancer Registry. Acta Pathol Microbiol Scand [A] 1980;88:251-4.
2. Rutqvist LE, Wallgren A. Inconsistencies in breast carcinoma registration. An investigation of 855 cases reported to the Swedish Cancer Registry. Acta Radiol Oncol 1983;22:109-12.
3. Garne JP, Aspegren K, Möller T. Validity of breast cancer registration from one hospital into the Swedish National Cancer Registry 1971-1991. Acta Oncol 1995;34:153-6.
4. Holmäng S, Hedelin H, Anderström C, Johansson SL. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 1995;153:1823-7.
5. Holmäng S, Hedelin H, Anderström C, Holmberg E, Johansson SL. Long-term followup of a bladder carcinoma cohort: routine followup urography is not necessary. J Urol 1998;160:45-8.
6. Andius P, Holmäng S. Bacillus Calmette-Guerin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression. BJU Int 2004;93:980-98.
7. Hermanek P, Sobin L. TNM classification of malignant tumors: renal pelvis and ureter, 4th ed. Berlin, Germany: Springer-Verlag; 1992. p. 151.
8. Epstein JI, Amin MB, Reuter VR, Mostofi FK, and the Bladder Consensus Conference Committee. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998;22:1435-48.
9. Mostofi FK, Davis CJ, Sesterhenn IA. Histological typing of urinary bladder tumors. World Health Organization International Classification of Tumours, 2nd ed. Berlin, Germany: Springer-Verlag; 1999.
10. Mellemgaard A, Carstensen B, Nørgaard N, Knudsen JB, Olsen JH. Trends in the incidence of cancer of the kidney, pelvis, ureter and bladder in Denmark 1943-1988. Scand J Urol Nephrol 1993;27:327-32.
11. Holmäng S, Hedelin H, Anderström C, Holmberg E, Johansson SL. Prospective registration of all patients in a geographical region with newly diagnosed bladder carcinomas during a two-year period. Scand J Urol Nephrol 2000;34:95-101.
12. Korhonen P, Malila N, Pukkala E, Teppo L, Albanes D, Virtamo J. The Finnish Cancer Registry as follow-up source of a large trial cohort. Acta Oncol 2002;41:381-8.
13. Linker DG, Whitmore WF. Ureteral carcinoma in situ. J Urol 1975;113:777-80.
14. Messing EM. Urothelial tumors of the urinary tract. In: Walsh P, Retik AB, Vaughan Jr ED, Wein AJ, editors. Campbell's urology, 8th ed. Philadelphia, PA: Saunders; 2002. p. 2754.